logo
#

Latest news with #Adia

Fine dining concept Adia returns in Newport Beach
Fine dining concept Adia returns in Newport Beach

Los Angeles Times

time5 days ago

  • Business
  • Los Angeles Times

Fine dining concept Adia returns in Newport Beach

During the pandemic when most restaurants were closed, local chefs Karlo Evaristo and Jared Ventura were busy creating their own dining concept, Adia. A roaming, pop-up restaurant, Adia blends Evaristo's Filipino heritage and cooking experience with Ventura's Italian background and cooking skills to create a multi-course, fine dining menu. 'Adia began as a fun passion project for us. We wanted to do a long-format tasting menu because we really enjoy those special meals,' said Ventura. 'Our first dinner featured 22 courses,' said Evaristo. 'We started with pop-ups and moved into private dining during the pandemic, as well as restaurant consulting.' In the past, Adia has popped up in Orange County restaurants like Trust in Downtown Santa Ana and commissaries like the Hood Kitchen Space in Costa Mesa. On Aug. 8 and 9, the two chefs partnered with chef Benjamin Martinek, culinary director of Pendry Newport Beach, on a special seven-course dinner, hosted at Viamara inside the hotel's members only Elwood Club. The Pendry keeps Martinek busy, overseeing all dining concepts there, including SET Steak & Sushi, the Pavilion, Tree Shack Pool Bar & Grill, Bar Pendry and other dining concepts within the Elwood Club, like the Pub and the Cabaret. While partnering with Adia put another item on his plate, Martinek was excited to offer the experience to patrons and guests, while Evaristo and Ventura were happy to present Adia for the first time since 2023. 'It was an extra special evening for us because it was the first pop-up we've done in a very long time,' said Ventura. 'It was an evening of reuniting with some really great old friends.' Adia's long hiatus is the result of Evaristo and Ventura's busy schedules. Since Adia began, both have been absorbed in additional culinary adventures. Ventura started Vivi's Pasta, a small batch fresh pasta company that uses Italian 00 flour, no seed oils and offers gluten free options. Made by hand in Costa Mesa, Vivi's Pasta is available at the Aliso Viejo Town Center Market on Saturdays and Stonegate Irvine Market on Sundays. Evaristo opened 6100 Bread at 728 N. Poinsettia St., in Santa Ana, a sourdough bread bakery with viral blue corn sourdough loaves and an ube cruffin. The bakery draws long lines each week while also producing bread for some of Orange County's best restaurants, including Viamara. The special two-night dinner featured a mix of French and Italian cuisine that highlighted each chef's signature skills while taking inspiration from the seasons. 'We start by doing what we did in the restaurants before, and that was look at what's best available in season and ingredients that make us very excited. Then we write a menu and it definitely has influences from the both of us,' said Evaristo. 'We first started cooking together over 10 years ago, so we definitely think alike.' A croissant course, for instance, presented a bite-sized cube of crunchy, buttery, laminated dough topped with rich duck liver and blackberry preserve. Another course included a perfectly seared scallop with a delicately stuffed choux farci, or cabbage roll, in beurre rouge. The pasta course was made up of fresh polenta tortellini with truffle miso and a dusting of parmigiano. While there isn't another Adia dinner on the event calendar at the Pendry yet, last week's dinner has galvanized the pop-up's return. 'We are both very busy, but also very excited about doing new Adia pop-ups,' said Ventura. 'I'm sure we will have one or two before the year ends.' Keep up with Adia's future events at or follow them on Instagram @restaurant_adia.

Yinson Production closes US$1bil investment from international consortium
Yinson Production closes US$1bil investment from international consortium

The Star

time17-06-2025

  • Business
  • The Star

Yinson Production closes US$1bil investment from international consortium

KUALA LUMPUR: Yinson Production has closed a US$1bil investment from a consortium comprising a wholly-owned subsidiary of the Abu Dhabi Investment Authority (Adia), and funds managed by British Columbia Investment Management Corporation (BCI) and RRJ Group (RRJ). In a statement, Yinson Production said it had inked a definitive agreement on Jan 14, 2025, and satisfied the closing conditions, including regulatory approvals and approval by the shareholders of Yinson Holdings Bhd. The investment is made through the issuance of US$1bil of redeemable convertible preferred shares (RCPS) and warrants by Yinson Production Offshore Holdings Limited, a newly established UK-based holding company. The agreement provides for the option to issue additional RCPS of up to US$ 500mil within 24 months from closing, subject to agreement. Upon closing, the investors funded the first tranche of US$300mil, of which US$200mil has been used for a special distribution to Yinson. The remaining US$700mil of committed RCPS will be called in up to three installments by December 2026. 'We are delighted to have successfully closed this significant investment from leading global investors. This investment not only reflects the quality of our business with highly visible cash flows and significant revenue backlog, but underscores the confidence in Yinson Production's long-term growth potential. "By further strengthening our financial foundation, this transaction positions us well to pursue new opportunities in a rapidly evolving offshore energy landscape,' said Yinson Production chief financial officer Markus Wenker.

CORRECTION FROM SOURCE: Adia Nutrition Inc. Successfully Uplists to OTCQB Venture Market in Record-Breaking Six Weeks and Completes SEC Rule 15c2-11 Compliance
CORRECTION FROM SOURCE: Adia Nutrition Inc. Successfully Uplists to OTCQB Venture Market in Record-Breaking Six Weeks and Completes SEC Rule 15c2-11 Compliance

Yahoo

time16-05-2025

  • Business
  • Yahoo

CORRECTION FROM SOURCE: Adia Nutrition Inc. Successfully Uplists to OTCQB Venture Market in Record-Breaking Six Weeks and Completes SEC Rule 15c2-11 Compliance

This release corrects and replaces the press release issued by Adia Nutrition Inc., on May 16, 2025, at 8:09 am EDT. Winter Park, Florida--(Newsfile Corp. - May 16, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and nutritional wellness, proudly announces its successful uplisting from the OTC Pink Sheets to the OTCQB Venture Market, effective today. This milestone, achieved in an unprecedented six weeks from the filing date of April 2nd, 2025, alongside the completion of SEC Rule 15c2-11 compliance, reinforces Adia's commitment to transparency, investor accessibility, and delivering on its promises with remarkable speed. OTCQB Uplisting To view an enhanced version of this graphic, please visit: The OTCQB uplisting process, which typically takes companies an average of 12-16 weeks from filing to approval, was executed by Adia Nutrition with exceptional efficiency. This rapid timeline-less than half the industry norm-demonstrates the company's operational excellence and close collaboration with OTC Markets Group, following an independent audit with Astra Audit and Advisory LLC on April 1, 2025. The completion of SEC Rule 15c2-11 compliance is a pivotal achievement, ensuring Adia's financial information is publicly available and meets stringent transparency standards. This rule requires broker-dealers to review and maintain current issuer information before quoting securities, enhancing investor confidence and enabling broader market participation. By satisfying 15c2-11, Adia Nutrition strengthens its credibility, facilitates trading liquidity, and positions itself as a trusted investment opportunity in the regenerative medicine sector. "Uplisting to OTCQB in six weeks and completing 15c2-11 compliance reflect our relentless focus on execution and transparency," said Larry Powalisz, CEO of Adia Nutrition Inc. "We promised our shareholders enhanced visibility, liquidity, and trust, and we've delivered-faster than most. This is yet another goal we set and achieved swiftly, paving the way for our continued growth and our ultimate vision of a Nasdaq Small Cap listing." The OTCQB Venture Market and 15c2-11 compliance elevate Adia Nutrition's ability to showcase its pioneering umbilical cord stem cell therapies and premium nutritional products to a wider investor base. This uplisting follows a series of rapid accomplishments, including the removal of the shell risk designation and the opening of its first Florida clinic for regenerative therapies, solidifying Adia's track record of setting ambitious targets and surpassing them. Adia Nutrition remains dedicated to revolutionizing healthcare through its medical division, specializing in umbilical cord stem cell (UCB-SC) therapies, and its supplement division, delivering premium, organic products. The company invites investors and stakeholders to join its journey as it expands its clinic network and drives innovation. For questions, inquiries or further information, please contact Larry Powalisz at ceo@ or 321-788-0850. About ADIA Nutrition Inc.:Adia Nutrition Inc. (OTCQB: ADIA) is a publicly traded company dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments. Website: Website: (X): @ADIA_Nutrition Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

CORRECTION FROM SOURCE: Adia Nutrition Inc. Successfully Uplists to OTCQB Venture Market in Record-Breaking Six Weeks and Completes SEC Rule 15c2-11 Compliance
CORRECTION FROM SOURCE: Adia Nutrition Inc. Successfully Uplists to OTCQB Venture Market in Record-Breaking Six Weeks and Completes SEC Rule 15c2-11 Compliance

Yahoo

time16-05-2025

  • Business
  • Yahoo

CORRECTION FROM SOURCE: Adia Nutrition Inc. Successfully Uplists to OTCQB Venture Market in Record-Breaking Six Weeks and Completes SEC Rule 15c2-11 Compliance

This release corrects and replaces the press release issued by Adia Nutrition Inc., on May 16, 2025, at 8:09 am EDT. Winter Park, Florida--(Newsfile Corp. - May 16, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and nutritional wellness, proudly announces its successful uplisting from the OTC Pink Sheets to the OTCQB Venture Market, effective today. This milestone, achieved in an unprecedented six weeks from the filing date of April 2nd, 2025, alongside the completion of SEC Rule 15c2-11 compliance, reinforces Adia's commitment to transparency, investor accessibility, and delivering on its promises with remarkable speed. OTCQB Uplisting To view an enhanced version of this graphic, please visit: The OTCQB uplisting process, which typically takes companies an average of 12-16 weeks from filing to approval, was executed by Adia Nutrition with exceptional efficiency. This rapid timeline-less than half the industry norm-demonstrates the company's operational excellence and close collaboration with OTC Markets Group, following an independent audit with Astra Audit and Advisory LLC on April 1, 2025. The completion of SEC Rule 15c2-11 compliance is a pivotal achievement, ensuring Adia's financial information is publicly available and meets stringent transparency standards. This rule requires broker-dealers to review and maintain current issuer information before quoting securities, enhancing investor confidence and enabling broader market participation. By satisfying 15c2-11, Adia Nutrition strengthens its credibility, facilitates trading liquidity, and positions itself as a trusted investment opportunity in the regenerative medicine sector. "Uplisting to OTCQB in six weeks and completing 15c2-11 compliance reflect our relentless focus on execution and transparency," said Larry Powalisz, CEO of Adia Nutrition Inc. "We promised our shareholders enhanced visibility, liquidity, and trust, and we've delivered-faster than most. This is yet another goal we set and achieved swiftly, paving the way for our continued growth and our ultimate vision of a Nasdaq Small Cap listing." The OTCQB Venture Market and 15c2-11 compliance elevate Adia Nutrition's ability to showcase its pioneering umbilical cord stem cell therapies and premium nutritional products to a wider investor base. This uplisting follows a series of rapid accomplishments, including the removal of the shell risk designation and the opening of its first Florida clinic for regenerative therapies, solidifying Adia's track record of setting ambitious targets and surpassing them. Adia Nutrition remains dedicated to revolutionizing healthcare through its medical division, specializing in umbilical cord stem cell (UCB-SC) therapies, and its supplement division, delivering premium, organic products. The company invites investors and stakeholders to join its journey as it expands its clinic network and drives innovation. For questions, inquiries or further information, please contact Larry Powalisz at ceo@ or 321-788-0850. About ADIA Nutrition Inc.:Adia Nutrition Inc. (OTCQB: ADIA) is a publicly traded company dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments. Website: Website: (X): @ADIA_Nutrition Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

MFT: Adia Remembers Her First Time Falling On Stage
MFT: Adia Remembers Her First Time Falling On Stage

Black America Web

time22-04-2025

  • Entertainment
  • Black America Web

MFT: Adia Remembers Her First Time Falling On Stage

Black America Web Featured Video CLOSE Erika Goldring For those who believe in His word, it will always be understood that God makes things happen with perfect timing. Take rising Christian R&B singer Adia for example. Even though she released her first and only album to-date over a decade ago, it's the work she's done in recent years alongside the Stellar Award's current 'Album Of The Year' reigning champ, Pastor Mike Jr., and in her own relaunched solo efforts that show just how talented she truly is. RELATED: My First Time : When Ne-Yo Met Beyoncé In a special segment of 'My First Time' that we're sure will garner a few laughs, Adia shares her humbling experience of falling on stage while on the come-up as part of a teenage gospel girl group. Most people would be mortified to get caught slipping while going up the steps, but thankfully our girl used it as the ultimate motivation in understanding how to keep pushing forward when life throws the unexpected your way. Also, it never hurts learning how to laugh at yourself. Watch the latest 'My First Time' below for a slippery story by way of rising contemporary gospel singer Adia: SEE ALSO

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store